share_log

Marinus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Noonberg Sarah B.

Marinus Pharmaceuticals | 4:持股变动声明-董事 Noonberg Sarah B.

SEC announcement ·  2023/05/17 21:08
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息